Russian Pharmaceutical Industry Leader
News
Pharmasyntez-Nord is a partner of the educational project Innovations on the Neva River
09.02.2024
Pharmasyntez-Nord is a partner of the educational project Innovations on the Neva River
Read more
Chief Executive Officer of Pharmasyntez-Nord is the leader of the rating in the Pharmaceutical Industry nomination
11.12.2023
Chief Executive Officer of Pharmasyntez-Nord is the leader of the rating in the Pharmaceutical Industry nomination
Read more
Badge of Honor for “Investor of the Year” went to Pharmasyntez-Nord
04.12.2023
Badge of Honor for “Investor of the Year” went to Pharmasyntez-Nord
Read more
The Pharmasyntez Group of Companies participated in the XXVII Russian Oncology Congress
17.11.2023
The Pharmasyntez Group of Companies participated in the XXVII Russian Oncology Congress
Read more
Bringing children to the workplace of parents
14.11.2023
Bringing children to the workplace of parents
Read more
Pharmasyntez-Nord gathered leading endocrinologists of the country on its site
01.11.2023
Pharmasyntez-Nord gathered leading endocrinologists of the country on its site
Read more
Pharmasyntez-Nord and Gan & Lee Pharmaceuticals signed Memorandum of Understanding
23.10.2023
Pharmasyntez-Nord and Gan & Lee Pharmaceuticals signed Memorandum of Understanding
Read more
Pharmasyntez-Nord launched antineoplastic drug Brestoker
19.10.2023
Pharmasyntez-Nord launched antineoplastic drug Brestoker
Read more
Pharmasyntez-Nord released the first lot of the drug product Myelodest
02.10.2023
Pharmasyntez-Nord released the first lot of the drug product Myelodest
Read more
The Pharmasyntez Group of Companies released the first lot of Insulin glargine
21.09.2023
The Pharmasyntez Group of Companies released the first lot of Insulin glargine
Read more
The Pharmasyntez Group of Companies starts production of gensulins in Russia
03.07.2023
The Pharmasyntez Group of Companies starts production of gensulins in Russia
Read more
The Pharmasyntez Group is investing 5 billion rubles in the construction of the fourth stage of the Pharmasyntez-Nord pharmaceutical complex
15.06.2023
The Pharmasyntez Group is investing 5 billion rubles in the construction of the fourth stage of the Pharmasyntez-Nord pharmaceutical complex
Read more
Representatives of the Healthy Life Forum Official Delegations Visited Pharmasyntez-Nord
28.03.2023
Representatives of the Healthy Life Forum Official Delegations Visited Pharmasyntez-Nord
Read more
Pharmasyntez-Nord supported the creating of the VYZOV youth community
23.03.2023
Pharmasyntez-Nord supported the creating of the VYZOV youth community
Read more
Natalia Popova, First Deputy General Director of Innopraktika company visited Pharmasyntez-Nord
22.03.2023
Natalia Popova, First Deputy General Director of Innopraktika company visited Pharmasyntez-Nord
Read more
Pharmasyntez-Nord is a partner of the Healthy Life Forum 2023
21.03.2023
Pharmasyntez-Nord is a partner of the Healthy Life Forum 2023
Read more
News: